- Corporate Officers - H
- Henry Christian O
Insider Trading History of Henry Christian O
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Henry Christian O since 2015.
This trader's CIK number is 1263805.
At the time of last reporting, Henry Christian O was the Officer of Wave Life Sciences Ltd.. (stock ticker symbol WVE).
Also see all insider trading activities at Wave Life Sciences Ltd..
Note that in the past
HENRY CHRISTIAN O also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Wave Life Sciences Ltd. (WVE) by Henry Christian O
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | WVE | 0 | $0 | 20,170 | $187,766 | 10,500 | $95,865 |
Yearly summary of insider trading at Illumina, Inc. (ILMN) by Henry Christian O
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2016 | ILMN | 0 | $0 | 34,095 | $5,480,287 | 36,500 | $463,000 |
2015 | ILMN | 0 | $0 | 48,228 | $9,888,184 | 21,500 | $1,490,810 |
Yearly summary of insider trading at Ginkgo Bioworks Holdings, Inc. (DNA) by Henry Christian O
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | DNA | 0 | $0 | 0 | $0 | 10,822 | $0 |
2024 | DNA | 0 | $0 | 0 | $0 | 105,263 | $0 |
2023 | DNA | 0 | $0 | 88,497 | $20,388,847 | 0 | $0 |
2022 | DNA | 0 | $0 | 53,989 | $135,017 | 0 | $0 |
Yearly summary of insider trading at Pacific Biosciences Of California, Inc. (PACB) by Henry Christian O
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | PACB | 0 | $0 | 259,909 | $488,109 | 0 | $0 |
2024 | PACB | 0 | $0 | 179,924 | $654,010 | 0 | $0 |
2023 | PACB | 0 | $0 | 152,143 | $1,536,197 | 0 | $0 |
2022 | PACB | 0 | $0 | 93,429 | $551,012 | 0 | $0 |
2021 | PACB | 0 | $0 | 90,520 | $2,435,893 | 0 | $0 |
Insider trading activities at 4 companies by Henry Christian O:
1. Wave Life Sciences Ltd. (WVE)
2. Illumina, Inc. (ILMN)
3. Ginkgo Bioworks Holdings, Inc. (DNA)
4. Pacific Biosciences Of California, Inc. (PACB)
Table 1. Insider trading of Wave Life Sciences Ltd. (WVE) by Henry Christian O
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-08-13 | WVE | Sale | 9,670 | 8.81 | 85,192 |
2025-03-20 | WVE | Option Ex | 10,500 | 9.13 | 95,865 |
2025-03-20 | WVE | Sale | 10,500 | 9.77 | 102,574 |
Table 2. Insider trading of Illumina, Inc. (ILMN) by Henry Christian O
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2016-07-11 | ILMN | Sale | 716 | 141.89 | 101,593 |
2016-06-15 | ILMN | Sale | 2,141 | 138.10 | 295,678 |
2016-05-25 | ILMN | Sale | 2,141 | 144.86 | 310,147 |
2016-05-17 | ILMN | Sale | 2,141 | 141.18 | 302,264 |
2016-04-27 | ILMN | Sale | 2,141 | 138.53 | 296,584 |
2016-04-18 | ILMN | Sale | 2,141 | 175.74 | 376,250 |
2016-04-13 | ILMN | Sale | 12,500 | 175.00 | 2,187,500 |
2016-04-13 | ILMN | Option Ex | 12,500 | 37.04 | 463,000 |
2016-04-05 | ILMN | Sale | 2,141 | 166.03 | 355,461 |
2016-03-23 | ILMN | Sale | 2,141 | 155.62 | 333,184 |
2016-03-14 | ILMN | Sale | 5,892 | 156.42 | 921,626 |
2016-03-03 | ILMN | Option Ex | 24,000 | .00 | 0 |
2015-07-15 | ILMN | Sale | 3,751 | 229.59 | 861,210 |
2015-07-16 | ILMN | Sale | 1,639 | 229.83 | 376,686 |
2015-06-24 | ILMN | Sale | 5,084 | 221.34 | 1,125,287 |
2015-06-17 | ILMN | Sale | 3,751 | 215.93 | 809,949 |
2015-06-10 | ILMN | Sale | 10,000 | 214.36 | 2,143,620 |
2015-06-10 | ILMN | Option Ex | 10,000 | 69.34 | 693,400 |
2015-05-14 | ILMN | Sale | 3,751 | 198.71 | 745,364 |
2015-05-05 | ILMN | Sale | 11,500 | 187.32 | 2,154,145 |
2015-05-05 | ILMN | Option Ex | 11,500 | 69.34 | 797,410 |
2015-04-15 | ILMN | Sale | 3,751 | 189.44 | 710,596 |
2015-03-16 | ILMN | Sale | 5,001 | 192.23 | 961,327 |
Table 3. Insider trading of Ginkgo Bioworks Holdings, Inc. (DNA) by Henry Christian O
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-06-11 | DNA | Option Ex | 10,822 | .00 | 0 |
2024-06-12 | DNA | Option Ex | 105,263 | .00 | 0 |
2023-11-02 | DNA | Sale | 4,500 | 1.39 | 6,255 |
2023-10-02 | DNA | Sale | 4,499 | 4,499.00 | 20,241,001 |
2023-09-05 | DNA | Sale | 4,499 | 2.23 | 10,032 |
2023-08-02 | DNA | Sale | 4,499 | 2.25 | 10,122 |
2023-07-03 | DNA | Sale | 4,499 | 1.89 | 8,503 |
2023-06-12 | DNA | Sale | 39,007 | 1.84 | 71,772 |
2023-06-02 | DNA | Sale | 4,499 | 1.63 | 7,333 |
2023-05-02 | DNA | Sale | 4,499 | 1.16 | 5,218 |
2023-04-03 | DNA | Sale | 4,499 | 1.32 | 5,938 |
2023-03-14 | DNA | Sale | 4,499 | 1.37 | 6,163 |
2023-02-02 | DNA | Sale | 4,499 | 2.10 | 9,447 |
2023-01-04 | DNA | Sale | 4,499 | 1.57 | 7,063 |
2022-12-02 | DNA | Sale | 4,499 | 1.85 | 8,323 |
2022-11-03 | DNA | Sale | 49,490 | 2.56 | 126,694 |
Table 4. Insider trading of Pacific Biosciences Of California, Inc. (PACB) by Henry Christian O
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-02-18 | PACB | Sale | 259,909 | 1.88 | 488,109 |
2024-09-16 | PACB | Sale | 98,907 | 1.75 | 172,691 |
2024-02-16 | PACB | Sale | 79,038 | 5.96 | 470,908 |
2024-02-20 | PACB | Sale | 1,979 | 5.26 | 10,411 |
2023-12-14 | PACB | Sale | 20,000 | 10.00 | 200,000 |
2023-09-18 | PACB | Sale | 96,844 | 10.12 | 980,254 |
2023-09-11 | PACB | Sale | 10,000 | 10.45 | 104,520 |
2023-08-17 | PACB | Sale | 10,000 | 10.50 | 105,000 |
2023-03-03 | PACB | Sale | 13,769 | 9.49 | 130,709 |
2023-02-17 | PACB | Sale | 1,530 | 10.27 | 15,714 |
2022-09-15 | PACB | Sale | 91,307 | 5.78 | 527,480 |
2022-02-17 | PACB | Sale | 2,122 | 11.09 | 23,532 |
2021-09-16 | PACB | Sale | 90,520 | 26.91 | 2,435,893 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Henry Christian O
(Officer of Wave Life Sciences Ltd. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.